Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its supply have become key issues for patients and healthcare practitioners. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant challenge to many